Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature

Apostolia Maria Tsimberidou; Jorge Medina; Jorge Cortes; Adan Rios; Glisson Bonnie; Stefan Faderl; Hagop Kantarjian; Guillermo Garcia-Manero

doi:10.1016/j.leukres.2003.10.020

Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature

Apostolia Maria Tsimberidou, Jorge Medina, Jorge Cortes, Adan Rios, Glisson Bonnie, Stefan Faderl, Hagop Kantarjian, Guillermo Garcia-Manero

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

We report a patient with acquired immune deficiency syndrome (AIDS) who developed Philadelphia-positive chronic myeloid leukemia (CML) and was successfully treated with imatinib mesylate. He achieved a complete cytogenetic response after 7 months of treatment. It appears that there is no in vivo interaction between imatinib and highly active anti-retroviral therapy (HAART) and these drugs can be concurrently administered with safety to patients with CML and AIDS.

Original language	English (US)
Pages (from-to)	657-660
Number of pages	4
Journal	Leukemia Research
Volume	28
Issue number	6
DOIs	https://doi.org/10.1016/j.leukres.2003.10.020
State	Published - Jun 1 2004
Externally published	Yes

Keywords

Acquired immune deficiency syndrome
Chronic myeloid leukemia
Imatinib mesylate

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.leukres.2003.10.020

Cite this

Tsimberidou, A. M., Medina, J., Cortes, J., Rios, A., Bonnie, G., Faderl, S., Kantarjian, H., & Garcia-Manero, G. (2004). Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature. Leukemia Research, 28(6), 657-660. https://doi.org/10.1016/j.leukres.2003.10.020

Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature. / Tsimberidou, Apostolia Maria; Medina, Jorge; Cortes, Jorge et al.
In: Leukemia Research, Vol. 28, No. 6, 01.06.2004, p. 657-660.

Research output: Contribution to journal › Article › peer-review

Tsimberidou, AM, Medina, J, Cortes, J, Rios, A, Bonnie, G, Faderl, S, Kantarjian, H & Garcia-Manero, G 2004, 'Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature', Leukemia Research, vol. 28, no. 6, pp. 657-660. https://doi.org/10.1016/j.leukres.2003.10.020

@article{243b94faf14a48a5b3c0d970a6f47f76,

title = "Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature",

abstract = "We report a patient with acquired immune deficiency syndrome (AIDS) who developed Philadelphia-positive chronic myeloid leukemia (CML) and was successfully treated with imatinib mesylate. He achieved a complete cytogenetic response after 7 months of treatment. It appears that there is no in vivo interaction between imatinib and highly active anti-retroviral therapy (HAART) and these drugs can be concurrently administered with safety to patients with CML and AIDS.",

keywords = "Acquired immune deficiency syndrome, Chronic myeloid leukemia, Imatinib mesylate",

author = "Tsimberidou, {Apostolia Maria} and Jorge Medina and Jorge Cortes and Adan Rios and Glisson Bonnie and Stefan Faderl and Hagop Kantarjian and Guillermo Garcia-Manero",

year = "2004",

month = jun,

day = "1",

doi = "10.1016/j.leukres.2003.10.020",

language = "English (US)",

volume = "28",

pages = "657--660",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Limited",

number = "6",

}

TY - JOUR

T1 - Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome

T2 - Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature

AU - Tsimberidou, Apostolia Maria

AU - Medina, Jorge

AU - Cortes, Jorge

AU - Rios, Adan

AU - Bonnie, Glisson

AU - Faderl, Stefan

AU - Kantarjian, Hagop

AU - Garcia-Manero, Guillermo

PY - 2004/6/1

Y1 - 2004/6/1

N2 - We report a patient with acquired immune deficiency syndrome (AIDS) who developed Philadelphia-positive chronic myeloid leukemia (CML) and was successfully treated with imatinib mesylate. He achieved a complete cytogenetic response after 7 months of treatment. It appears that there is no in vivo interaction between imatinib and highly active anti-retroviral therapy (HAART) and these drugs can be concurrently administered with safety to patients with CML and AIDS.

AB - We report a patient with acquired immune deficiency syndrome (AIDS) who developed Philadelphia-positive chronic myeloid leukemia (CML) and was successfully treated with imatinib mesylate. He achieved a complete cytogenetic response after 7 months of treatment. It appears that there is no in vivo interaction between imatinib and highly active anti-retroviral therapy (HAART) and these drugs can be concurrently administered with safety to patients with CML and AIDS.

KW - Acquired immune deficiency syndrome

KW - Chronic myeloid leukemia

KW - Imatinib mesylate

UR - http://www.scopus.com/inward/record.url?scp=2142768442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142768442&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2003.10.020

DO - 10.1016/j.leukres.2003.10.020

M3 - Article

C2 - 15120945

AN - SCOPUS:2142768442

SN - 0145-2126

VL - 28

SP - 657

EP - 660

JO - Leukemia Research

JF - Leukemia Research

IS - 6

ER -

Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this